Cutting-Edge Models for Neurological and Psychiatric Disorders
  • View Times: 35
  • |
  • Release Date: 2024-04-12
  • psychosis
  • Parkinson's disease
  • stem cells
  • stroke
  • neuroimaging
  • migraine
  • epilepsy
  • aphasia
  • depression
  • exercise
Video Introduction

This video is adapted from 10.3390/biomedicines12030613

Neuroscience, neurology, and psychiatry are rapidly evolving fields that aim to understand the complex mechanisms underlying brain function and dysfunction, as well as to develop effective interventions for various neurological and psychiatric disorders [1][2][3]. Recent advances in molecular biology, genetics, epigenetics, pharmacology, and neuroimaging have provided new insights into the etiology, pathophysiology, diagnosis, and treatment of these disorders [4][5][6][7][8]. However, there are still many challenges and gaps in translating basic research findings into clinical applications and improving the quality of life of patients and their families [9][10][11]. One pivotal area of interest within these disciplines is neuroplasticity, the brain’s remarkable ability to reorganize and adapt throughout life [12][13][14][15][16]. Neuroplasticity encompasses various mechanisms, including synaptic plasticity, neurogenesis, and alterations in neuronal connectivity, which underpin crucial processes such as learning, memory, and recovery from injury or disease [17][18][19][20]. In tandem with understanding neuroplasticity, non-invasive brain stimulation (NIBS) techniques such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) have emerged as promising therapeutic modalities [21][22][23]. These techniques can modulate neuroplasticity by inducing changes in cortical excitability and connectivity, offering potential avenues for ameliorating symptoms associated with conditions such as depression, schizophrenia (SCZ), and chronic pain [24][25][26]. Research indicates that NIBS holds promise for enhancing cognitive function, alleviating mood disturbances, and reducing pain perception by targeting specific brain regions implicated in these processes [27][28][29]. Moreover, combining NIBS with cognitive training, psychotherapy, or pharmacotherapy may enhance treatment outcomes synergistically [30][31][32][33]. Researchers aimed to showcase the latest developments and innovations in bench-to-bedside translational research, as well as highlight the opportunities and limitations of various models and methods [34][35][36]. Researchers also aimed to foster interdisciplinary collaboration and communication among researchers and clinicians working in different fields and domains. The Special Issue received 12 high-quality submissions from authors across the world, covering a wide range of topics and disorders, such as Alzheimer’s disease, Parkinson’s disease (PD), Huntington’s disease, SCZ, bipolar disorder, depression, anxiety, autism, addiction, and pain. The research presented novel findings and perspectives on the molecular and cellular mechanisms, genetic and epigenetic factors, environmental influences, pharmacological interventions, and biomarkers of these disorders, complementing previous research [37][38][39]. The research also discussed the challenges and future directions of translational research in neuroscience, neurology, and psychiatry. Below, authors briefly summarize the main contributions and implications of each research.

  1. Bassett, D.S.; Sporns, O. Network neuroscience. Nat. Neurosci. 2017, 20, 353–364.
  2. Huys, Q.J.; Maia, T.V.; Frank, M.J. Computational psychiatry as a bridge from neuroscience to clinical applications. Nat. Neurosci. 2016, 19, 404–413.
  3. Insel, T.R.; Quirion, R. Psychiatry as a clinical neuroscience discipline. JAMA 2005, 294, 2221–2224.
  4. Sullivan, P.F.; Posthuma, D. Biological pathways and networks implicated in psychiatric disorders. Curr. Opin. Behav. Sci. 2015, 2, 58–68.
  5. Geschwind, D.H.; Flint, J. Genetics and genomics of psychiatric disease. Science 2015, 349, 1489–1494.
  6. Grezenko, H.; Ekhator, C.; Nwabugwu, N.U.; Ganga, H.; Affaf, M.; Abdelaziz, A.M.; Rehman, A.; Shehryar, A.; Abbasi, F.A.; Bellegarde, S.B. Epigenetics in neurological and psychiatric disorders: A comprehensive review of current understanding and future perspectives. Cureus 2023, 15, e43960.
  7. Nathan, P.J.; Phan, K.L.; Harmer, C.J.; Mehta, M.A.; Bullmore, E.T. Increasing pharmacological knowledge about human neurological and psychiatric disorders through functional neuroimaging and its application in drug discovery. Curr. Opin. Pharmacol. 2014, 14, 54–61.
  8. Iorio-Morin, C.; Sarica, C.; Elias, G.J.; Harmsen, I.; Hodaie, M. Neuroimaging of psychiatric disorders. Prog. Brain Res. 2022, 270, 149–169.
  9. Insel, T.R. Translating scientific opportunity into public health impact: A strategic plan for research on mental illness. Arch. Gen. Psychiatry 2009, 66, 128–133.
  10. Schumann, G.; Binder, E.B.; Holte, A.; de Kloet, E.R.; Oedegaard, K.J.; Robbins, T.W.; Walker-Tilley, T.R.; Bitter, I.; Brown, V.J.; Buitelaar, J. Stratified medicine for mental disorders. Eur. Neuropsychopharmacol. 2014, 24, 5–50.
  11. Di Luca, M.; Destrebecq, F.; Kramer, S. Future of the aging brain: Bridging the gap between research and policy. Aging Brain 2021, 1, 100002.
  12. Tanaka, M.; Schmidt, A.; Hassel, S. Case Reports in Neuroimaging and Stimulation. Front. Psychiatry 2023, 14, 1264669.
  13. Tanaka, M.; Diano, M.; Battaglia, S. Insights into structural and functional organization of the brain: Evidence from neuroimaging and non-invasive brain stimulation techniques. Front. Psychiatry 2023, 14, 1225755.
  14. Tortora, F.; Hadipour, A.L.; Battaglia, S.; Falzone, A.; Avenanti, A.; Vicario, C.M. The role of Serotonin in fear learning and memory: A systematic review of human studies. Brain Sci. 2023, 13, 1197.
  15. Gandhi, A.B.; Kaleem, I.; Alexander, J.; Hisbulla, M.; Kannichamy, V.; Antony, I.; Mishra, V.; Banerjee, A.; Khan, S. Neuroplasticity Improves Bipolar Disorder: A Review. Cureus 2020, 12, e11241.
  16. Rădulescu, I.; Drăgoi, A.M.; Trifu, S.C.; Cristea, M.B. Neuroplasticity and depression: Rewiring the brain’s networks through pharmacological therapy (Review). Exp. Ther. Med. 2021, 22, 1131.
  17. Battaglia, S.; Nazzi, C.; Thayer, J.F. Genetic differences associated with dopamine and serotonin release mediate fear-induced bradycardia in the human brain. Transl. Psychiatry 2024, 14, 24.
  18. Battaglia, S.; Nazzi, C.; Thayer, J. Heart’s tale of trauma: Fear-conditioned heart rate changes in post-traumatic stress disorder. Acta Psychiatr. Scand. 2023.
  19. Battaglia, S.; Nazzi, C.; Thayer, J. Fear-induced bradycardia in mental disorders: Foundations, current advances, future perspectives. Neurosci. Biobehav. Rev. 2023, 149, 105163.
  20. Jászberényi, M.; Thurzó, B.; Bagosi, Z.; Vécsei, L.; Tanaka, M. The Orexin/Hypocretin System, the Peptidergic Regulator of Vigilance, Orchestrates Adaptation to Stress. Biomedicines 2024, 12, 448.
  21. Terranova, C.; Rizzo, V.; Cacciola, A.; Chillemi, G.; Calamuneri, A.; Milardi, D.; Quartarone, A. Is there a future for non-invasive brain stimulation as a therapeutic tool? Front. Neurol. 2019, 9, 1146.
  22. Bandeira, I.D.; Lins-Silva, D.H.; Barouh, J.L.; Faria-Guimarães, D.; Dorea-Bandeira, I.; Souza, L.S.; Alves, G.S.; Brunoni, A.R.; Nitsche, M.; Fregni, F. Neuroplasticity and non-invasive brain stimulation in the developing brain. Prog. Brain Res. 2021, 264, 57–89.
  23. Hanoglu, L.; Velioglu, H.A.; Hanoglu, T.; Yulug, B. Neuroimaging-guided transcranial magnetic and direct current stimulation in MCI: Toward an individual, effective and disease-modifying treatment. Clin. EEG Neurosci. 2023, 54, 82–90.
  24. Battaglia, S.; Di Fazio, C.; Mazzà, M.; Tamietto, M.; Avenanti, A. Targeting Human Glucocorticoid Receptors in Fear Learning: A Multiscale Integrated Approach to Study Functional Connectivity. Int. J. Mol. Sci. 2024, 25, 864.
  25. Battaglia, M.R.; Di Fazio, C.; Battaglia, S. Activated tryptophan-kynurenine metabolic system in the human brain is associated with learned fear. Front. Mol. Neurosci. 2023, 16, 1217090.
  26. Battaglia, S.; Di Fazio, C.; Vicario, C.M.; Avenanti, A. Neuropharmacological modulation of N-methyl-D-aspartate, noradrenaline and endocannabinoid receptors in fear extinction learning: Synaptic transmission and plasticity. Int. J. Mol. Sci. 2023, 24, 5926.
  27. Xu, Y.; Qiu, Z.; Zhu, J.; Liu, J.; Wu, J.; Tao, J.; Chen, L. The modulation effect of non-invasive brain stimulation on cognitive function in patients with mild cognitive impairment: A systematic review and meta-analysis of randomized controlled trials. BMC Neurosci. 2019, 20, 2.
  28. Brunoni, A.R.; Palm, U. Transcranial direct current stimulation in psychiatry: Mood disorders, schizophrenia and other psychiatric diseases. In Practical Guide to Transcranial Direct Current Stimulation: Principles, Procedures and Applications; Springer: Cham, Switzerland, 2019; pp. 431–471.
  29. Kong, Q.; Li, T.; Reddy, S.; Hodges, S.; Kong, J. Brain stimulation targets for chronic pain: Insights from meta-analysis, functional connectivity and literature review. Neurotherapeutics 2023, 21, e00297.
  30. Gregorio, F.; Battaglia, S. Advances in EEG-based functional connectivity approaches to the study of the central nervous system in health and disease. Adv. Clin. Exp. Med. 2023, 32, 607–612.
  31. Di Gregorio, F.; Steinhauser, M.; Maier, M.E.; Thayer, J.F.; Battaglia, S. Error-related cardiac deceleration: Functional interplay between error-related brain activity and autonomic nervous system in performance monitoring. Neurosci. Biobehav. Rev. 2024, 157, 105542.
  32. Ippolito, G.; Bertaccini, R.; Tarasi, L.; Di Gregorio, F.; Trajkovic, J.; Battaglia, S.; Romei, V. The role of alpha oscillations among the main neuropsychiatric disorders in the adult and developing human brain: Evidence from the last 10 years of research. Biomedicines 2022, 10, 3189.
  33. Balogh, L.; Tanaka, M.; Török, N.; Vécsei, L.; Taguchi, S. Crosstalk between existential phenomenological psychotherapy and neurological sciences in mood and anxiety disorders. Biomedicines 2021, 9, 340.
  34. Tanaka, M.; Szabó, Á.; Vécsei, L.; Giménez-Llort, L. Emerging translational research in neurological and psychiatric diseases: From in vitro to in vivo models. Int. J. Mol. Sci. 2023, 24, 15739.
  35. Tanaka, M.; Vécsei, L. Editorial of Special Issue “Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry”. Biomedicines 2021, 9, 517.
  36. Tanaka, M.; Szabó, Á.; Vécsei, L. Integrating Armchair, Bench, and Bedside Research for Behavioral Neurology and Neuropsychiatry: Editorial. Biomedicines 2022, 10, 2999.
  37. Tanaka, M.; Vécsei, L. Monitoring the redox status in multiple sclerosis. Biomedicines 2020, 8, 406.
  38. Tanaka, M.; Bohár, Z.; Vécsei, L. Are kynurenines accomplices or principal villains in dementia? Maintenance of kynurenine metabolism. Molecules 2020, 25, 564.
  39. de Oliveira Zanuso, B.; Dos Santos, A.R.d.O.; Miola, V.F.B.; Campos, L.M.G.; Spilla, C.S.G.; Barbalho, S.M. Panax ginseng and aging related disorders: A systematic review. Exp. Gerontol. 2022, 161, 111731.
Full Transcript


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Tanaka, M.; Vécsei, L. Cutting-Edge Models for Neurological and Psychiatric Disorders. Encyclopedia. Available online: (accessed on 25 May 2024).
Tanaka M, Vécsei L. Cutting-Edge Models for Neurological and Psychiatric Disorders. Encyclopedia. Available at: Accessed May 25, 2024.
Tanaka, Masaru, László Vécsei. "Cutting-Edge Models for Neurological and Psychiatric Disorders" Encyclopedia, (accessed May 25, 2024).
Tanaka, M., & Vécsei, L. (2024, April 12). Cutting-Edge Models for Neurological and Psychiatric Disorders. In Encyclopedia.
Tanaka, Masaru and László Vécsei. "Cutting-Edge Models for Neurological and Psychiatric Disorders." Encyclopedia. Web. 12 April, 2024.
Video Production Service